“…Several trials used MMF in place of CyA, resulting in improved renal function with no increase in acute rejection. 18,19 However, these trials did not have an extended follow-up to determine whether there was a major impact on renal dysfunction and no increase in chronic rejection. There have been no studies of SRL use in chronic renal toxicity after OLT.…”